<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://patholines.org/index.php?action=history&amp;feed=atom&amp;title=Template%3AHepatocellular_adenoma_versus_carcinoma</id>
	<title>Template:Hepatocellular adenoma versus carcinoma - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://patholines.org/index.php?action=history&amp;feed=atom&amp;title=Template%3AHepatocellular_adenoma_versus_carcinoma"/>
	<link rel="alternate" type="text/html" href="https://patholines.org/index.php?title=Template:Hepatocellular_adenoma_versus_carcinoma&amp;action=history"/>
	<updated>2026-08-15T08:19:31Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://patholines.org/index.php?title=Template:Hepatocellular_adenoma_versus_carcinoma&amp;diff=3154&amp;oldid=prev</id>
		<title>Mikael Häggström: /* Hepatocellular adenoma versus carcinoma */ adenoma</title>
		<link rel="alternate" type="text/html" href="https://patholines.org/index.php?title=Template:Hepatocellular_adenoma_versus_carcinoma&amp;diff=3154&amp;oldid=prev"/>
		<updated>2021-02-11T14:53:22Z</updated>

		<summary type="html">&lt;p&gt;&lt;span class=&quot;autocomment&quot;&gt;Hepatocellular adenoma versus carcinoma: &lt;/span&gt; adenoma&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 10:53, 11 February 2021&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot;&gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;===Hepatocellular adenoma versus carcinoma===&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;===Hepatocellular adenoma versus carcinoma===&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[File:Histopathology of inflammatory hepatocellular adenoma.jpg|thumb|Histopathology of inflammatory hepatocellular adenoma, with inflammatory cells and minor atypia.&amp;lt;ref name=&quot;Bioulac-SageSempoux2013&quot;&amp;gt;{{cite journal|last1=Bioulac-Sage|first1=Paulette|last2=Sempoux|first2=Christine|last3=Possenti|first3=Laurent|last4=Frulio|first4=Nora|last5=Laumonier|first5=Hervé|last6=Laurent|first6=Christophe|last7=Chiche|first7=Laurence|last8=Frédéric Blanc|first8=Jean|last9=Saric|first9=Jean|last10=Trillaud|first10=Hervé|last11=Le Bail|first11=Brigitte|last12=Balabaud|first12=Charles|title=Pathological Diagnosis of Hepatocellular Cellular Adenoma according to the Clinical Context|journal=International Journal of Hepatology|volume=2013|year=2013|pages=1–13|issn=2090-3448|doi=10.1155/2013/253261}}&amp;lt;/ref&amp;gt;]]&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[File:Histopathology of inflammatory hepatocellular adenoma.jpg|thumb|Histopathology of inflammatory hepatocellular &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&#039;&#039;&#039;&lt;/ins&gt;adenoma&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&#039;&#039;&#039;&lt;/ins&gt;, with inflammatory cells and minor atypia.&amp;lt;ref name=&quot;Bioulac-SageSempoux2013&quot;&amp;gt;{{cite journal|last1=Bioulac-Sage|first1=Paulette|last2=Sempoux|first2=Christine|last3=Possenti|first3=Laurent|last4=Frulio|first4=Nora|last5=Laumonier|first5=Hervé|last6=Laurent|first6=Christophe|last7=Chiche|first7=Laurence|last8=Frédéric Blanc|first8=Jean|last9=Saric|first9=Jean|last10=Trillaud|first10=Hervé|last11=Le Bail|first11=Brigitte|last12=Balabaud|first12=Charles|title=Pathological Diagnosis of Hepatocellular Cellular Adenoma according to the Clinical Context|journal=International Journal of Hepatology|volume=2013|year=2013|pages=1–13|issn=2090-3448|doi=10.1155/2013/253261}}&amp;lt;/ref&amp;gt;]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;A &amp;#039;&amp;#039;&amp;#039;hepatocellular adenoma&amp;#039;&amp;#039;&amp;#039;, in contrast to a carcinoma, has a well-defined border between the lesion and background liver, and is composed of hepatocytes with less significant cytologic atypia.&amp;lt;ref&amp;gt;{{cite web|url=https://www.pathologyoutlines.com/topic/livertumorhepatocellularadenoma.html|title=Liver &amp;amp; intrahepatic bile ducts - Benign / nonneoplastic - Hepatocellular adenoma|author=Author: Avani Pendse, M.D., Ph.D.|website=Pathology Outlines}} Topic Completed: 1 October 2018. Minor changes: 30 September 2020&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;A &amp;#039;&amp;#039;&amp;#039;hepatocellular adenoma&amp;#039;&amp;#039;&amp;#039;, in contrast to a carcinoma, has a well-defined border between the lesion and background liver, and is composed of hepatocytes with less significant cytologic atypia.&amp;lt;ref&amp;gt;{{cite web|url=https://www.pathologyoutlines.com/topic/livertumorhepatocellularadenoma.html|title=Liver &amp;amp; intrahepatic bile ducts - Benign / nonneoplastic - Hepatocellular adenoma|author=Author: Avani Pendse, M.D., Ph.D.|website=Pathology Outlines}} Topic Completed: 1 October 2018. Minor changes: 30 September 2020&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Mikael Häggström</name></author>
	</entry>
	<entry>
		<id>https://patholines.org/index.php?title=Template:Hepatocellular_adenoma_versus_carcinoma&amp;diff=3151&amp;oldid=prev</id>
		<title>Mikael Häggström: Emphasized</title>
		<link rel="alternate" type="text/html" href="https://patholines.org/index.php?title=Template:Hepatocellular_adenoma_versus_carcinoma&amp;diff=3151&amp;oldid=prev"/>
		<updated>2021-02-11T14:49:55Z</updated>

		<summary type="html">&lt;p&gt;Emphasized&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 10:49, 11 February 2021&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot;&gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;===Hepatocellular adenoma versus carcinoma===&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;===Hepatocellular adenoma versus carcinoma===&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[File:Histopathology of inflammatory hepatocellular adenoma.jpg|thumb|Histopathology of inflammatory hepatocellular adenoma, with inflammatory cells and minor atypia.&amp;lt;ref name=&amp;quot;Bioulac-SageSempoux2013&amp;quot;&amp;gt;{{cite journal|last1=Bioulac-Sage|first1=Paulette|last2=Sempoux|first2=Christine|last3=Possenti|first3=Laurent|last4=Frulio|first4=Nora|last5=Laumonier|first5=Hervé|last6=Laurent|first6=Christophe|last7=Chiche|first7=Laurence|last8=Frédéric Blanc|first8=Jean|last9=Saric|first9=Jean|last10=Trillaud|first10=Hervé|last11=Le Bail|first11=Brigitte|last12=Balabaud|first12=Charles|title=Pathological Diagnosis of Hepatocellular Cellular Adenoma according to the Clinical Context|journal=International Journal of Hepatology|volume=2013|year=2013|pages=1–13|issn=2090-3448|doi=10.1155/2013/253261}}&amp;lt;/ref&amp;gt;]]&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[File:Histopathology of inflammatory hepatocellular adenoma.jpg|thumb|Histopathology of inflammatory hepatocellular adenoma, with inflammatory cells and minor atypia.&amp;lt;ref name=&amp;quot;Bioulac-SageSempoux2013&amp;quot;&amp;gt;{{cite journal|last1=Bioulac-Sage|first1=Paulette|last2=Sempoux|first2=Christine|last3=Possenti|first3=Laurent|last4=Frulio|first4=Nora|last5=Laumonier|first5=Hervé|last6=Laurent|first6=Christophe|last7=Chiche|first7=Laurence|last8=Frédéric Blanc|first8=Jean|last9=Saric|first9=Jean|last10=Trillaud|first10=Hervé|last11=Le Bail|first11=Brigitte|last12=Balabaud|first12=Charles|title=Pathological Diagnosis of Hepatocellular Cellular Adenoma according to the Clinical Context|journal=International Journal of Hepatology|volume=2013|year=2013|pages=1–13|issn=2090-3448|doi=10.1155/2013/253261}}&amp;lt;/ref&amp;gt;]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;A &#039;&#039;&#039;hepatocellular adenoma&#039;&#039;&#039;, in contrast, has a well-defined border between the lesion and background liver, and is composed of hepatocytes with less significant cytologic atypia.&amp;lt;ref&amp;gt;{{cite web|url=https://www.pathologyoutlines.com/topic/livertumorhepatocellularadenoma.html|title=Liver &amp;amp; intrahepatic bile ducts - Benign / nonneoplastic - Hepatocellular adenoma|author=Author: Avani Pendse, M.D., Ph.D.|website=Pathology Outlines}} Topic Completed: 1 October 2018. Minor changes: 30 September 2020&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;A &#039;&#039;&#039;hepatocellular adenoma&#039;&#039;&#039;, in contrast &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;to a carcinoma&lt;/ins&gt;, has a well-defined border between the lesion and background liver, and is composed of hepatocytes with less significant cytologic atypia.&amp;lt;ref&amp;gt;{{cite web|url=https://www.pathologyoutlines.com/topic/livertumorhepatocellularadenoma.html|title=Liver &amp;amp; intrahepatic bile ducts - Benign / nonneoplastic - Hepatocellular adenoma|author=Author: Avani Pendse, M.D., Ph.D.|website=Pathology Outlines}} Topic Completed: 1 October 2018. Minor changes: 30 September 2020&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Both hepatocellular adenoma and well-differentiated hepatocellular carcinoma may display:&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Both hepatocellular adenoma and well-differentiated hepatocellular carcinoma may display:&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*&amp;#039;&amp;#039;&amp;#039;Steatosis&amp;#039;&amp;#039;&amp;#039;: A steatotic hepatocellular carcinoma is a common variant, found most commonly in small, well-differentiated tumors.&amp;lt;ref name=&amp;quot;ChanYu2016&amp;quot;&amp;gt;{{cite journal|last1=Chan|first1=Anthony W H|last2=Yu|first2=Shuangni|last3=Yu|first3=Yau-Hei|last4=Tong|first4=Joanna H M|last5=Wang|first5=Lei|last6=Tin|first6=Edith K Y|last7=Chong|first7=Charing C N|last8=Chan|first8=Stephen L|last9=Wong|first9=Grace L H|last10=Wong|first10=Vincent W S|last11=Chan|first11=Henry L Y|last12=Lai|first12=Paul B S|last13=To|first13=Ka-Fai|title=Steatotic hepatocellular carcinoma: a variant associated with metabolic factors and late tumour relapse|journal=Histopathology|volume=69|issue=6|year=2016|pages=971–984|issn=03090167|doi=10.1111/his.13029}}&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*&amp;#039;&amp;#039;&amp;#039;Steatosis&amp;#039;&amp;#039;&amp;#039;: A steatotic hepatocellular carcinoma is a common variant, found most commonly in small, well-differentiated tumors.&amp;lt;ref name=&amp;quot;ChanYu2016&amp;quot;&amp;gt;{{cite journal|last1=Chan|first1=Anthony W H|last2=Yu|first2=Shuangni|last3=Yu|first3=Yau-Hei|last4=Tong|first4=Joanna H M|last5=Wang|first5=Lei|last6=Tin|first6=Edith K Y|last7=Chong|first7=Charing C N|last8=Chan|first8=Stephen L|last9=Wong|first9=Grace L H|last10=Wong|first10=Vincent W S|last11=Chan|first11=Henry L Y|last12=Lai|first12=Paul B S|last13=To|first13=Ka-Fai|title=Steatotic hepatocellular carcinoma: a variant associated with metabolic factors and late tumour relapse|journal=Histopathology|volume=69|issue=6|year=2016|pages=971–984|issn=03090167|doi=10.1111/his.13029}}&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*&amp;#039;&amp;#039;&amp;#039;Portal triads&amp;#039;&amp;#039;&amp;#039;, which commonly persist in well-differentiated hepatocellular carcinomas.&amp;lt;ref name=&amp;quot;MotohashiOkudaira1992&amp;quot;&amp;gt;{{cite journal|last1=Motohashi|first1=Ikuko|last2=Okudaira|first2=Masahiko|last3=Takai|first3=Tomoko|last4=Kaneko|first4=Satoshi|last5=Ikeda|first5=Noriaki|title=Morphological differences between hepatocellular carcinoma and hepatocellular carcinomalike lesions|journal=Hepatology|volume=16|issue=1|year=1992|pages=118–126|issn=02709139|doi=10.1002/hep.1840160120}}&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*&amp;#039;&amp;#039;&amp;#039;Portal triads&amp;#039;&amp;#039;&amp;#039;, which commonly persist in well-differentiated hepatocellular carcinomas.&amp;lt;ref name=&amp;quot;MotohashiOkudaira1992&amp;quot;&amp;gt;{{cite journal|last1=Motohashi|first1=Ikuko|last2=Okudaira|first2=Masahiko|last3=Takai|first3=Tomoko|last4=Kaneko|first4=Satoshi|last5=Ikeda|first5=Noriaki|title=Morphological differences between hepatocellular carcinoma and hepatocellular carcinomalike lesions|journal=Hepatology|volume=16|issue=1|year=1992|pages=118–126|issn=02709139|doi=10.1002/hep.1840160120}}&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Mikael Häggström</name></author>
	</entry>
	<entry>
		<id>https://patholines.org/index.php?title=Template:Hepatocellular_adenoma_versus_carcinoma&amp;diff=3150&amp;oldid=prev</id>
		<title>Mikael Häggström: Templated</title>
		<link rel="alternate" type="text/html" href="https://patholines.org/index.php?title=Template:Hepatocellular_adenoma_versus_carcinoma&amp;diff=3150&amp;oldid=prev"/>
		<updated>2021-02-11T14:49:08Z</updated>

		<summary type="html">&lt;p&gt;Templated&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;===Hepatocellular adenoma versus carcinoma===&lt;br /&gt;
[[File:Histopathology of inflammatory hepatocellular adenoma.jpg|thumb|Histopathology of inflammatory hepatocellular adenoma, with inflammatory cells and minor atypia.&amp;lt;ref name=&amp;quot;Bioulac-SageSempoux2013&amp;quot;&amp;gt;{{cite journal|last1=Bioulac-Sage|first1=Paulette|last2=Sempoux|first2=Christine|last3=Possenti|first3=Laurent|last4=Frulio|first4=Nora|last5=Laumonier|first5=Hervé|last6=Laurent|first6=Christophe|last7=Chiche|first7=Laurence|last8=Frédéric Blanc|first8=Jean|last9=Saric|first9=Jean|last10=Trillaud|first10=Hervé|last11=Le Bail|first11=Brigitte|last12=Balabaud|first12=Charles|title=Pathological Diagnosis of Hepatocellular Cellular Adenoma according to the Clinical Context|journal=International Journal of Hepatology|volume=2013|year=2013|pages=1–13|issn=2090-3448|doi=10.1155/2013/253261}}&amp;lt;/ref&amp;gt;]]&lt;br /&gt;
A &amp;#039;&amp;#039;&amp;#039;hepatocellular adenoma&amp;#039;&amp;#039;&amp;#039;, in contrast, has a well-defined border between the lesion and background liver, and is composed of hepatocytes with less significant cytologic atypia.&amp;lt;ref&amp;gt;{{cite web|url=https://www.pathologyoutlines.com/topic/livertumorhepatocellularadenoma.html|title=Liver &amp;amp; intrahepatic bile ducts - Benign / nonneoplastic - Hepatocellular adenoma|author=Author: Avani Pendse, M.D., Ph.D.|website=Pathology Outlines}} Topic Completed: 1 October 2018. Minor changes: 30 September 2020&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Both hepatocellular adenoma and well-differentiated hepatocellular carcinoma may display:&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;Steatosis&amp;#039;&amp;#039;&amp;#039;: A steatotic hepatocellular carcinoma is a common variant, found most commonly in small, well-differentiated tumors.&amp;lt;ref name=&amp;quot;ChanYu2016&amp;quot;&amp;gt;{{cite journal|last1=Chan|first1=Anthony W H|last2=Yu|first2=Shuangni|last3=Yu|first3=Yau-Hei|last4=Tong|first4=Joanna H M|last5=Wang|first5=Lei|last6=Tin|first6=Edith K Y|last7=Chong|first7=Charing C N|last8=Chan|first8=Stephen L|last9=Wong|first9=Grace L H|last10=Wong|first10=Vincent W S|last11=Chan|first11=Henry L Y|last12=Lai|first12=Paul B S|last13=To|first13=Ka-Fai|title=Steatotic hepatocellular carcinoma: a variant associated with metabolic factors and late tumour relapse|journal=Histopathology|volume=69|issue=6|year=2016|pages=971–984|issn=03090167|doi=10.1111/his.13029}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;Portal triads&amp;#039;&amp;#039;&amp;#039;, which commonly persist in well-differentiated hepatocellular carcinomas.&amp;lt;ref name=&amp;quot;MotohashiOkudaira1992&amp;quot;&amp;gt;{{cite journal|last1=Motohashi|first1=Ikuko|last2=Okudaira|first2=Masahiko|last3=Takai|first3=Tomoko|last4=Kaneko|first4=Satoshi|last5=Ikeda|first5=Noriaki|title=Morphological differences between hepatocellular carcinoma and hepatocellular carcinomalike lesions|journal=Hepatology|volume=16|issue=1|year=1992|pages=118–126|issn=02709139|doi=10.1002/hep.1840160120}}&amp;lt;/ref&amp;gt;&lt;/div&gt;</summary>
		<author><name>Mikael Häggström</name></author>
	</entry>
</feed>